BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2414181)

  • 1. TFX immunotherapy in children with ALL during remission.
    Traczewska M; Chmielewska D; Ochocka M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(4):525-36. PubMed ID: 2414181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin activity in patients with cellular immunodeficiency.
    Wara DW; Goldstein AL; Doyle NE; Ammann AJ
    N Engl J Med; 1975 Jan; 292(2):70-4. PubMed ID: 1078552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune status in children with acute lymphocytic leukemia. Observations in 67 cases.
    Bardare M; Pietrogrande MC; Corona F; Varin E; Carnelli V; Masera G
    Helv Paediatr Acta; 1978 Aug; 33(3):241-50. PubMed ID: 309463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the immune status of children with acute lymphocytic leukaemia. I. Early phase before and after first remission.
    Hitzig WH; Plüss HJ; Joller P; Pilgrim U; Tacier-Eugster H; Jakob M
    Clin Exp Immunol; 1976 Dec; 26(3):403-13. PubMed ID: 1087593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG as active immunotherapy in children with acute lymphoblastic leukemia in longstanding remission: positive effects on remission duration and immunologic parameters.
    Miale TD; Yocum D; Yocum C
    Biomedicine; 1978 May; 28(2):96-104. PubMed ID: 276382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymphocyte subpopulations in acute lymphoblastic leukemia in children].
    Schneer JH; Mănăliă T; Dimitriu AG
    Rev Pediatr Obstet Ginecol Pediatr; 1978; 27(2):169-75. PubMed ID: 96512
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoimmunotherapy with levamisole during maintenance therapy in children with acute lymphoblastic leukemia.
    Bogusławska-Jaworska J; Raus Z
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):719-23. PubMed ID: 6960810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulation in recurrent respiratory tract infections therapy in children.
    Prusek W; Jankowski A; Radomska G; Wieczorek E; Podwysocka M
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):289-302. PubMed ID: 3502238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis.
    Greaves MF; Janossy G; Peto J; Kay H
    Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy in previously treated acute lymphatic leukemia.
    Leventhal BG; LePourhiet A; Halterman RH; Henderson ES; Herberman RB
    Natl Cancer Inst Monogr; 1973 Dec; 39():177-87. PubMed ID: 4274495
    [No Abstract]   [Full Text] [Related]  

  • 11. T-cell depletion and in vitro thymosin inducibility in asthmatic children.
    Byrom NA; Caballero F; Campbell MA; Chooi M; Lane AM; Hugh-Jones K; Timlin DM; Hobbs JR
    Clin Exp Immunol; 1978 Mar; 31(3):490-8. PubMed ID: 306906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the immune status of children with acute lymphocytic leukaemia. II. In remission with and without cytostatic treatment.
    Hitzig WH; Plüss HJ; Joller P; Pilgrim U; Tacier-Eugster H; Jakob M
    Clin Exp Immunol; 1976 Dec; 26(3):414-8. PubMed ID: 1087594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy].
    Kaftański R
    Acta Haematol Pol; 1979; 10(2):99-106. PubMed ID: 289275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin-inducible lymphocytes in the peripheral blood of patients with malignant melanoma.
    Byrom NA; Campbell MA; Dean AJ; Timlin DM; Volkers C; Bodenham DC; Hobbs JR
    Cancer Treat Rep; 1978 Nov; 62(11):1769-74. PubMed ID: 310343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological rebound following cessation of chemotherapy in 15 acute lymphoid leukemia patients in complete remission.
    De Rossi G; Tribalto M; Monarca B; Bolle C; Pasqualetti D; Mandelli F
    Biomedicine; 1978 Feb; 29(1):11-3. PubMed ID: 276383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of the abnormal ratio of OKT4+ to OKT8+ peripheral blood lymphocytes in patients suffering from juvenile arthritis (JCA) by the extract from calf thymuses.
    Podwysocka M; Wieczorek Z; Zimecki M; Prusek W; Wieczorek E; Spiegel K
    Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):127-32. PubMed ID: 2619496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunostimulation with preparation TFX in lymphoblastic leukemia].
    Chmielewska D; Traczewska M; Ochocka M
    Pediatr Pol; 1980 Nov; 55(11):1213-9. PubMed ID: 6936711
    [No Abstract]   [Full Text] [Related]  

  • 18. The study of T-lymphocytes, granulocyte's phagocytic activity, and adherent cells in patients with acute lymphoblastic leukemia during levamisol therapy.
    Bogusławska-Jaworska J; Chybicka A; Pisarek J
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):855-8. PubMed ID: 312090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic hormone (THF) therapy in immunosuppressed children with lymphoproliferative neoplasia and generalized varicella.
    Zaizov R; Vogel R; Cohen I; Varsano I; Shohat B; Rotter V; Trainin N
    Biomedicine; 1977 Apr; 27(3):105-8. PubMed ID: 268220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin synthesis by lymphocytes of eight immuno-deficient children.
    Bernatowska E; Górski A; Korczak-Kowalska G; Dzierzanowska D; Madaliński K
    Arch Immunol Ther Exp (Warsz); 1985; 33(4):595-601. PubMed ID: 3909993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.